Shire plc - Statement re: Media Speculation - KTVN Channel 2 - Reno Tahoe News Weather, Video -

Shire plc - Statement re: Media Speculation

  • Wendy Damonte's Health Watch ReportsMore>>

  • Request Remind Me 2 Kit

    Request a Remind Me 2 Kit

         More >>
  • New Treatment for Deaf Children

    New Treatment for Deaf Children

    Friday, July 25 2014 6:56 PM EDT2014-07-25 22:56:18 GMT
    An experimental procedure is giving deaf children the chance to hear. Doctors at Children's Hospital in Los Angeles are taking part in an experimental trial.More >>
    An experimental procedure is giving deaf children the chance to hear. Doctors at Children's Hospital in Los Angeles are taking part in an experimental trial.More >>
  • Free Yoga Classes for MS Patients in South Lake Tahoe

    Free Yoga Classes for MS Patients in South Lake Tahoe

    Friday, July 25 2014 4:34 PM EDT2014-07-25 20:34:18 GMT
    Multiple Sclerosis patients can get complimentary weekly yoga classes starting next month in South Lake Tahoe. The free MS Yoga Project weekly classes begin Monday, August 4th.More >>
    Multiple Sclerosis patients can get complimentary weekly yoga classes starting next month in South Lake Tahoe. The free MS Yoga Project weekly classes begin Monday, August 4th.More >>

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Shire plc

DUBLIN, July 11, 2014 /PRNewswire/ --


Not for release, publication or distribution (in whole or in part) in, into or from any jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction. 

Shire plc ("Shire" or the "Company") (LSE: SHP, NASDAQ: SHPG) notes the Bloomberg article this afternoon.  Shire confirms it has held a meeting with representatives of AbbVie.

This statement is being made by Shire without the prior agreement or approval of AbbVie.

A further update will be made when appropriate.  Shareholders are strongly advised to take no action in relation to AbbVie's proposal.  There can be no certainty that any firm offer will be made nor as to the terms on which any firm offer might be made.

A copy of this announcement will be available at http://www.shire.com.  The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement.

Notes to editors 

Shire enables people with life-altering conditions to lead better lives.

Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.

We focus on providing treatments in Neuroscience, Rare Diseases, Gastrointestinal, and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmology.

http://www.shire.com

 

CONTACTS 

Shire 

Stephanie Fagan

+1-201-572-9581

FTI Consulting (Media Adviser to the Company) 

Andrew Lorenz (London)

+44-77-7564-1807

Ben Atwell (London)

+44-20-3727-1000

David B. Roady (New York)

+1-212-850-5600

Robert Stanislaro (New York)

+1-212-850-5600


©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and Sarkes Tarzian, Inc. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service.